FDA
approval
· 2014-12-23
FDA Approved: NAMZARIC — Original Application (Allergan, Inc.)
Summary
FDA approved NAMZARIC, a fixed-dose combination of memantine hydrochloride and donepezil hydrochloride, under an original application from Allergan for the trea…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for NAMZARIC (MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE)